Skip to main content

Animations

MJFF Publications

5541 - 5550 of 6514 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2021
  • 2022
  • 2022
  • 2021
  • 2021
  • 2022
  • 2021
  • 2022
  • Summary Details
    OPEN
    Title: Australian Parkinson’s Genetics Study (APGS): pilot (n=1532)
    Journal Name: BMJ Open
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1136/bmjopen-2021-052032
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2112712119
    Citation Count: 53
  • Summary Details
    OPEN
    Title: True ultra-low-dose amyloid PET/MRI enhanced with deep learning for clinical interpretation
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00259-020-05151-9
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000013218
    Citation Count: 183
  • Summary Details
    OPEN
    Title: Functional MAOB Gene Intron 13 Polymorphism Predicts Dyskinesia in Parkinson’s Disease
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2022/5597503
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000013121
    Citation Count: 128
  • Summary Details
    OPEN
    Title: Genetic risk, adherence to a healthy lifestyle, and cognitive decline in African Americans and European Americans
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.12435
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Lamina-specific immunohistochemical signatures in the olfactory bulb of healthy, Alzheimer’s and Parkinson’s disease patients
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-022-03032-5
    Citation Count: 33
  • Summary Details
    OPEN
    Title: PhosPiR: an automated phosphoproteomic pipeline in R
    Journal Name: Briefings in Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/bib/bbab510
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Holocue: A Wearable Holographic Cueing Application for Alleviating Freezing of Gait in Parkinson's Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2021.628388
    Citation Count: 27
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.